Search company, investor...
Cleveland Biotech company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Private Equity | Alive

Total Raised


Last Raised

$5.2M | 8 yrs ago

About Cleveland Biotech

Cleveland Biotech (CBio) is an Applied Environmental Biotechnology company providing tailored solutions to fat, food, oil and grease (FOG) waste management in the commercial kitchen industry.

Cleveland Biotech Headquarters Location

Beaufort Studio Atlantic Wharf

Cardiff, Wales, CF10 4AH,

United Kingdom

+44 (0)29 2067 4098

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cleveland Biotech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cleveland Biotech is included in 1 Expert Collection, including Smart Cities.


Smart Cities

2,371 items

Smart building tech covers energy management/HVAC tech, occupancy/security tech, connectivity/IoT tech, construction materials, robotics use in buildings, and the metaverse/virtual buildings.

Cleveland Biotech Patents

Cleveland Biotech has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Synthetic estrogens, Estranes, Anionic surfactants, Phenols, Estrogens


Application Date


Grant Date



Related Topics

Synthetic estrogens, Estranes, Anionic surfactants, Phenols, Estrogens



Latest Cleveland Biotech News

Cleveland Biotech combines with Welsh rival Biological Preparations

Mar 19, 2015

LinkedIn Ben Hoskyns MD of CBio Cleveland Biotech A Teesside waste management company is combining with a Welsh firm to become a UK market leader in biological solutions. Stockton-based Cleveland Biotech (CBio) has grown rapidly since a £4.4m management buyout in 2013 led by managing director Ben Hoskyns, a move which was backed by £3m of investment from Newcastle-based NVM Private Equity. The firm creates bacterial-busting products which can break down organic pollutants including oil, grease and limescale, which are found on supermarket shelves in the UK and Europe. Now NVM has invested a further £3.5m to create a new business that will combine the knowledge and resources of Cleveland Biotech with another firm in its portfolio – Caerphilly-based Biological Preparations (BP). Established in 2008, BP specialises in the development of biotechnology solutions for a wide range of sectors including food and drink, water treatment, agricultural and cleaning services. The company formulates and blends its unique products using microbial, enzyme, plant extract, organic acid and biocide technology, all of which are supplied from its own facility in Caerphilly. The initial funding injected into the Stockton business by NVM has been used alongside the further £3.5m investment in a deal totalling £10.4m to create the new combined entity. The two firms plan to continue under their own names, but will offer the full range of biological cleaning and waste products to a wider customer base, effectively bringing together two competitors to create a greater force in the market. James Patterson, managing director of BP, said: “We are delighted to be partnering with CBio and NVM to create an enlarged business that will offer an extensive range of products and services to exploit the growing demand for biotechnology solutions for waste control and cleaning requirements.” Ben Hoskyns, managing director of CBio, said: “There are obvious synergies between CBio and BP, especially as both businesses have been competitors. “We have both built up a strong reputation in the biological treatment market, so bringing together our FOG solutions with BP’s complementary cleaning solutions will offer considerable benefits to both our existing and new customer bases.” Mauro Biagioni, partner of NVM Private Equity, said: “The CBio and BP management teams have over 60 years of combined experience in the biological treatment marketing. “Both teams have built successful and competing businesses, so the partnership will give the new company a market leading position – especially in light of increasing pressures on companies that produce waste to actively demonstrate their green credentials.”

  • Where is Cleveland Biotech's headquarters?

    Cleveland Biotech's headquarters is located at Beaufort Studio, Cardiff.

  • What is Cleveland Biotech's latest funding round?

    Cleveland Biotech's latest funding round is Private Equity.

  • How much did Cleveland Biotech raise?

    Cleveland Biotech raised a total of $5.2M.

  • Who are the investors of Cleveland Biotech?

    Investors of Cleveland Biotech include NVM Private Equity.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.